nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—SIGMAR1—Progesterone—uterine cancer	0.226	0.34	CbGbCtD
Fluoxetine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0488	0.0732	CbGbCtD
Fluoxetine—CYP3A5—Progesterone—uterine cancer	0.0482	0.0723	CbGbCtD
Fluoxetine—CYP2C19—Progesterone—uterine cancer	0.0389	0.0583	CbGbCtD
Fluoxetine—CYP1A2—Progesterone—uterine cancer	0.0359	0.0538	CbGbCtD
Fluoxetine—CYP2C9—Progesterone—uterine cancer	0.0323	0.0485	CbGbCtD
Fluoxetine—ABCB1—Progesterone—uterine cancer	0.0314	0.0471	CbGbCtD
Fluoxetine—CYP2D6—Progesterone—uterine cancer	0.0296	0.0443	CbGbCtD
Fluoxetine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0284	0.0426	CbGbCtD
Fluoxetine—ABCB1—Dactinomycin—uterine cancer	0.0249	0.0373	CbGbCtD
Fluoxetine—CYP3A5—Etoposide—uterine cancer	0.0216	0.0324	CbGbCtD
Fluoxetine—CYP3A4—Progesterone—uterine cancer	0.0188	0.0282	CbGbCtD
Fluoxetine—CYP2B6—Doxorubicin—uterine cancer	0.0187	0.028	CbGbCtD
Fluoxetine—CYP1A2—Etoposide—uterine cancer	0.0161	0.0241	CbGbCtD
Fluoxetine—ABCB1—Etoposide—uterine cancer	0.014	0.0211	CbGbCtD
Fluoxetine—ABCB1—Doxorubicin—uterine cancer	0.00958	0.0144	CbGbCtD
Fluoxetine—CYP2D6—Doxorubicin—uterine cancer	0.00903	0.0135	CbGbCtD
Fluoxetine—CYP3A4—Etoposide—uterine cancer	0.00841	0.0126	CbGbCtD
Fluoxetine—CYP3A4—Doxorubicin—uterine cancer	0.00574	0.00861	CbGbCtD
Fluoxetine—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00266	1	CbGdCrCtD
Fluoxetine—HTR2A—artery—uterine cancer	0.000848	0.0477	CbGeAlD
Fluoxetine—SIGMAR1—myometrium—uterine cancer	0.000769	0.0432	CbGeAlD
Fluoxetine—ORM1—endometrium—uterine cancer	0.00064	0.036	CbGeAlD
Fluoxetine—SIGMAR1—uterine cervix—uterine cancer	0.000598	0.0337	CbGeAlD
Fluoxetine—SIGMAR1—smooth muscle tissue—uterine cancer	0.000582	0.0327	CbGeAlD
Fluoxetine—SIGMAR1—decidua—uterine cancer	0.00057	0.0321	CbGeAlD
Fluoxetine—SIGMAR1—endometrium—uterine cancer	0.000541	0.0304	CbGeAlD
Fluoxetine—ORM1—female reproductive system—uterine cancer	0.00053	0.0298	CbGeAlD
Fluoxetine—SIGMAR1—mammalian vulva—uterine cancer	0.000524	0.0294	CbGeAlD
Fluoxetine—SLC6A2—decidua—uterine cancer	0.000505	0.0284	CbGeAlD
Fluoxetine—SIGMAR1—uterus—uterine cancer	0.000499	0.0281	CbGeAlD
Fluoxetine—HTR2C—female reproductive system—uterine cancer	0.000476	0.0268	CbGeAlD
Fluoxetine—SLC6A4—female reproductive system—uterine cancer	0.000451	0.0254	CbGeAlD
Fluoxetine—SIGMAR1—female gonad—uterine cancer	0.000408	0.0229	CbGeAlD
Fluoxetine—SIGMAR1—vagina—uterine cancer	0.000406	0.0228	CbGeAlD
Fluoxetine—SLC6A2—female reproductive system—uterine cancer	0.000397	0.0224	CbGeAlD
Fluoxetine—CYP3A5—uterine cervix—uterine cancer	0.000393	0.0221	CbGeAlD
Fluoxetine—CYP1A2—renal system—uterine cancer	0.000382	0.0215	CbGeAlD
Fluoxetine—CYP3A5—renal system—uterine cancer	0.000368	0.0207	CbGeAlD
Fluoxetine—CYP2B6—renal system—uterine cancer	0.000366	0.0206	CbGeAlD
Fluoxetine—CYP2C19—vagina—uterine cancer	0.000338	0.019	CbGeAlD
Fluoxetine—HTR2A—epithelium—uterine cancer	0.000322	0.0181	CbGeAlD
Fluoxetine—ORM1—lymph node—uterine cancer	0.00031	0.0174	CbGeAlD
Fluoxetine—HTR2A—smooth muscle tissue—uterine cancer	0.00031	0.0174	CbGeAlD
Fluoxetine—HTR2A—renal system—uterine cancer	0.000298	0.0168	CbGeAlD
Fluoxetine—CYP2B6—female reproductive system—uterine cancer	0.000293	0.0165	CbGeAlD
Fluoxetine—CYP2C9—female reproductive system—uterine cancer	0.00029	0.0163	CbGeAlD
Fluoxetine—CYP3A4—renal system—uterine cancer	0.000276	0.0155	CbGeAlD
Fluoxetine—ALB—lymph node—uterine cancer	0.000272	0.0153	CbGeAlD
Fluoxetine—CYP2D6—renal system—uterine cancer	0.000272	0.0153	CbGeAlD
Fluoxetine—ABCB1—myometrium—uterine cancer	0.000269	0.0151	CbGeAlD
Fluoxetine—CYP3A5—female gonad—uterine cancer	0.000268	0.0151	CbGeAlD
Fluoxetine—CYP3A5—vagina—uterine cancer	0.000267	0.015	CbGeAlD
Fluoxetine—CYP2B6—vagina—uterine cancer	0.000265	0.0149	CbGeAlD
Fluoxetine—SIGMAR1—lymph node—uterine cancer	0.000262	0.0148	CbGeAlD
Fluoxetine—HTR2A—female reproductive system—uterine cancer	0.000239	0.0134	CbGeAlD
Fluoxetine—SLC6A2—lymph node—uterine cancer	0.000233	0.0131	CbGeAlD
Fluoxetine—CYP3A4—female reproductive system—uterine cancer	0.000221	0.0124	CbGeAlD
Fluoxetine—CYP2D6—female reproductive system—uterine cancer	0.000218	0.0122	CbGeAlD
Fluoxetine—HTR2A—vagina—uterine cancer	0.000216	0.0122	CbGeAlD
Fluoxetine—ABCB1—epithelium—uterine cancer	0.000211	0.0119	CbGeAlD
Fluoxetine—ABCB1—uterine cervix—uterine cancer	0.000209	0.0118	CbGeAlD
Fluoxetine—ABCB1—decidua—uterine cancer	0.000199	0.0112	CbGeAlD
Fluoxetine—CYP2D6—female gonad—uterine cancer	0.000198	0.0111	CbGeAlD
Fluoxetine—ABCB1—renal system—uterine cancer	0.000195	0.011	CbGeAlD
Fluoxetine—ABCB1—endometrium—uterine cancer	0.000189	0.0106	CbGeAlD
Fluoxetine—ABCB1—mammalian vulva—uterine cancer	0.000183	0.0103	CbGeAlD
Fluoxetine—ABCB1—uterus—uterine cancer	0.000174	0.00979	CbGeAlD
Fluoxetine—ABCB1—female reproductive system—uterine cancer	0.000157	0.0088	CbGeAlD
Fluoxetine—ABCB1—female gonad—uterine cancer	0.000142	0.00801	CbGeAlD
Fluoxetine—ABCB1—vagina—uterine cancer	0.000142	0.00796	CbGeAlD
Fluoxetine—Thrombocytopenia—Etoposide—uterine cancer	9.98e-05	0.000319	CcSEcCtD
Fluoxetine—Tachycardia—Etoposide—uterine cancer	9.95e-05	0.000318	CcSEcCtD
Fluoxetine—Eosinophilia—Epirubicin—uterine cancer	9.95e-05	0.000318	CcSEcCtD
Fluoxetine—Liver function test abnormal—Doxorubicin—uterine cancer	9.93e-05	0.000318	CcSEcCtD
Fluoxetine—Skin disorder—Etoposide—uterine cancer	9.9e-05	0.000317	CcSEcCtD
Fluoxetine—Dry skin—Doxorubicin—uterine cancer	9.86e-05	0.000315	CcSEcCtD
Fluoxetine—Hyperhidrosis—Etoposide—uterine cancer	9.85e-05	0.000315	CcSEcCtD
Fluoxetine—Pancreatitis—Epirubicin—uterine cancer	9.85e-05	0.000315	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Doxorubicin—uterine cancer	9.83e-05	0.000314	CcSEcCtD
Fluoxetine—Hypokalaemia—Doxorubicin—uterine cancer	9.79e-05	0.000313	CcSEcCtD
Fluoxetine—Angina pectoris—Epirubicin—uterine cancer	9.79e-05	0.000313	CcSEcCtD
Fluoxetine—Breast disorder—Doxorubicin—uterine cancer	9.72e-05	0.000311	CcSEcCtD
Fluoxetine—Anorexia—Etoposide—uterine cancer	9.72e-05	0.000311	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	9.69e-05	0.00031	CcSEcCtD
Fluoxetine—Bronchitis—Epirubicin—uterine cancer	9.66e-05	0.000309	CcSEcCtD
Fluoxetine—Diarrhoea—Dactinomycin—uterine cancer	9.64e-05	0.000308	CcSEcCtD
Fluoxetine—Pancytopenia—Epirubicin—uterine cancer	9.54e-05	0.000305	CcSEcCtD
Fluoxetine—Hypotension—Etoposide—uterine cancer	9.53e-05	0.000305	CcSEcCtD
Fluoxetine—Gastritis—Doxorubicin—uterine cancer	9.52e-05	0.000304	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	9.49e-05	0.000303	CcSEcCtD
Fluoxetine—Muscular weakness—Doxorubicin—uterine cancer	9.49e-05	0.000303	CcSEcCtD
Fluoxetine—Dysuria—Epirubicin—uterine cancer	9.4e-05	0.0003	CcSEcCtD
Fluoxetine—Abdominal distension—Doxorubicin—uterine cancer	9.36e-05	0.000299	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Epirubicin—uterine cancer	9.34e-05	0.000299	CcSEcCtD
Fluoxetine—Dysphagia—Doxorubicin—uterine cancer	9.3e-05	0.000297	CcSEcCtD
Fluoxetine—Influenza—Doxorubicin—uterine cancer	9.3e-05	0.000297	CcSEcCtD
Fluoxetine—Asthma—Doxorubicin—uterine cancer	9.3e-05	0.000297	CcSEcCtD
Fluoxetine—Pollakiuria—Epirubicin—uterine cancer	9.28e-05	0.000297	CcSEcCtD
Fluoxetine—Eosinophilia—Doxorubicin—uterine cancer	9.21e-05	0.000294	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Epirubicin—uterine cancer	9.17e-05	0.000293	CcSEcCtD
Fluoxetine—ABCB1—lymph node—uterine cancer	9.16e-05	0.00515	CbGeAlD
Fluoxetine—Paraesthesia—Etoposide—uterine cancer	9.15e-05	0.000293	CcSEcCtD
Fluoxetine—Weight increased—Epirubicin—uterine cancer	9.15e-05	0.000292	CcSEcCtD
Fluoxetine—Pancreatitis—Doxorubicin—uterine cancer	9.12e-05	0.000291	CcSEcCtD
Fluoxetine—Weight decreased—Epirubicin—uterine cancer	9.09e-05	0.000291	CcSEcCtD
Fluoxetine—Dyspnoea—Etoposide—uterine cancer	9.09e-05	0.000291	CcSEcCtD
Fluoxetine—Hyperglycaemia—Epirubicin—uterine cancer	9.06e-05	0.00029	CcSEcCtD
Fluoxetine—Somnolence—Etoposide—uterine cancer	9.06e-05	0.00029	CcSEcCtD
Fluoxetine—Angina pectoris—Doxorubicin—uterine cancer	9.06e-05	0.00029	CcSEcCtD
Fluoxetine—Pneumonia—Epirubicin—uterine cancer	9.01e-05	0.000288	CcSEcCtD
Fluoxetine—Drowsiness—Epirubicin—uterine cancer	8.96e-05	0.000286	CcSEcCtD
Fluoxetine—Vomiting—Dactinomycin—uterine cancer	8.96e-05	0.000286	CcSEcCtD
Fluoxetine—Bronchitis—Doxorubicin—uterine cancer	8.94e-05	0.000286	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	8.88e-05	0.000284	CcSEcCtD
Fluoxetine—Rash—Dactinomycin—uterine cancer	8.88e-05	0.000284	CcSEcCtD
Fluoxetine—Decreased appetite—Etoposide—uterine cancer	8.86e-05	0.000283	CcSEcCtD
Fluoxetine—Pancytopenia—Doxorubicin—uterine cancer	8.83e-05	0.000282	CcSEcCtD
Fluoxetine—Renal failure—Epirubicin—uterine cancer	8.81e-05	0.000282	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Etoposide—uterine cancer	8.8e-05	0.000281	CcSEcCtD
Fluoxetine—Fatigue—Etoposide—uterine cancer	8.79e-05	0.000281	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Epirubicin—uterine cancer	8.78e-05	0.000281	CcSEcCtD
Fluoxetine—Stomatitis—Epirubicin—uterine cancer	8.73e-05	0.000279	CcSEcCtD
Fluoxetine—Jaundice—Epirubicin—uterine cancer	8.73e-05	0.000279	CcSEcCtD
Fluoxetine—Pain—Etoposide—uterine cancer	8.72e-05	0.000279	CcSEcCtD
Fluoxetine—Constipation—Etoposide—uterine cancer	8.72e-05	0.000279	CcSEcCtD
Fluoxetine—Conjunctivitis—Epirubicin—uterine cancer	8.71e-05	0.000278	CcSEcCtD
Fluoxetine—Urinary tract infection—Epirubicin—uterine cancer	8.71e-05	0.000278	CcSEcCtD
Fluoxetine—Dysuria—Doxorubicin—uterine cancer	8.69e-05	0.000278	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Doxorubicin—uterine cancer	8.64e-05	0.000276	CcSEcCtD
Fluoxetine—Sweating—Epirubicin—uterine cancer	8.59e-05	0.000275	CcSEcCtD
Fluoxetine—Pollakiuria—Doxorubicin—uterine cancer	8.59e-05	0.000275	CcSEcCtD
Fluoxetine—Haematuria—Epirubicin—uterine cancer	8.54e-05	0.000273	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Doxorubicin—uterine cancer	8.49e-05	0.000271	CcSEcCtD
Fluoxetine—Weight increased—Doxorubicin—uterine cancer	8.46e-05	0.000271	CcSEcCtD
Fluoxetine—Epistaxis—Epirubicin—uterine cancer	8.45e-05	0.00027	CcSEcCtD
Fluoxetine—Weight decreased—Doxorubicin—uterine cancer	8.41e-05	0.000269	CcSEcCtD
Fluoxetine—Sinusitis—Epirubicin—uterine cancer	8.41e-05	0.000269	CcSEcCtD
Fluoxetine—Feeling abnormal—Etoposide—uterine cancer	8.4e-05	0.000269	CcSEcCtD
Fluoxetine—Hyperglycaemia—Doxorubicin—uterine cancer	8.39e-05	0.000268	CcSEcCtD
Fluoxetine—Nausea—Dactinomycin—uterine cancer	8.37e-05	0.000267	CcSEcCtD
Fluoxetine—Pneumonia—Doxorubicin—uterine cancer	8.34e-05	0.000267	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Etoposide—uterine cancer	8.34e-05	0.000266	CcSEcCtD
Fluoxetine—Drowsiness—Doxorubicin—uterine cancer	8.29e-05	0.000265	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	8.22e-05	0.000263	CcSEcCtD
Fluoxetine—Bradycardia—Epirubicin—uterine cancer	8.19e-05	0.000262	CcSEcCtD
Fluoxetine—Renal failure—Doxorubicin—uterine cancer	8.15e-05	0.000261	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Doxorubicin—uterine cancer	8.13e-05	0.00026	CcSEcCtD
Fluoxetine—Urticaria—Etoposide—uterine cancer	8.1e-05	0.000259	CcSEcCtD
Fluoxetine—Haemoglobin—Epirubicin—uterine cancer	8.08e-05	0.000258	CcSEcCtD
Fluoxetine—Jaundice—Doxorubicin—uterine cancer	8.08e-05	0.000258	CcSEcCtD
Fluoxetine—Stomatitis—Doxorubicin—uterine cancer	8.08e-05	0.000258	CcSEcCtD
Fluoxetine—Rhinitis—Epirubicin—uterine cancer	8.06e-05	0.000258	CcSEcCtD
Fluoxetine—Body temperature increased—Etoposide—uterine cancer	8.06e-05	0.000258	CcSEcCtD
Fluoxetine—Abdominal pain—Etoposide—uterine cancer	8.06e-05	0.000258	CcSEcCtD
Fluoxetine—Conjunctivitis—Doxorubicin—uterine cancer	8.06e-05	0.000258	CcSEcCtD
Fluoxetine—Urinary tract infection—Doxorubicin—uterine cancer	8.06e-05	0.000258	CcSEcCtD
Fluoxetine—Haemorrhage—Epirubicin—uterine cancer	8.04e-05	0.000257	CcSEcCtD
Fluoxetine—Hepatitis—Epirubicin—uterine cancer	8.04e-05	0.000257	CcSEcCtD
Fluoxetine—Hypoaesthesia—Epirubicin—uterine cancer	8e-05	0.000256	CcSEcCtD
Fluoxetine—Pharyngitis—Epirubicin—uterine cancer	7.98e-05	0.000255	CcSEcCtD
Fluoxetine—Sweating—Doxorubicin—uterine cancer	7.95e-05	0.000254	CcSEcCtD
Fluoxetine—Oedema peripheral—Epirubicin—uterine cancer	7.92e-05	0.000253	CcSEcCtD
Fluoxetine—Haematuria—Doxorubicin—uterine cancer	7.9e-05	0.000253	CcSEcCtD
Fluoxetine—Epistaxis—Doxorubicin—uterine cancer	7.82e-05	0.00025	CcSEcCtD
Fluoxetine—Sinusitis—Doxorubicin—uterine cancer	7.78e-05	0.000249	CcSEcCtD
Fluoxetine—Visual impairment—Epirubicin—uterine cancer	7.75e-05	0.000248	CcSEcCtD
Fluoxetine—Erythema multiforme—Epirubicin—uterine cancer	7.6e-05	0.000243	CcSEcCtD
Fluoxetine—Bradycardia—Doxorubicin—uterine cancer	7.58e-05	0.000242	CcSEcCtD
Fluoxetine—Hypersensitivity—Etoposide—uterine cancer	7.51e-05	0.00024	CcSEcCtD
Fluoxetine—Tinnitus—Epirubicin—uterine cancer	7.5e-05	0.00024	CcSEcCtD
Fluoxetine—Haemoglobin—Doxorubicin—uterine cancer	7.48e-05	0.000239	CcSEcCtD
Fluoxetine—Rhinitis—Doxorubicin—uterine cancer	7.46e-05	0.000239	CcSEcCtD
Fluoxetine—Haemorrhage—Doxorubicin—uterine cancer	7.44e-05	0.000238	CcSEcCtD
Fluoxetine—Hepatitis—Doxorubicin—uterine cancer	7.44e-05	0.000238	CcSEcCtD
Fluoxetine—Hypoaesthesia—Doxorubicin—uterine cancer	7.4e-05	0.000237	CcSEcCtD
Fluoxetine—Pharyngitis—Doxorubicin—uterine cancer	7.39e-05	0.000236	CcSEcCtD
Fluoxetine—Oedema peripheral—Doxorubicin—uterine cancer	7.33e-05	0.000234	CcSEcCtD
Fluoxetine—Asthenia—Etoposide—uterine cancer	7.31e-05	0.000234	CcSEcCtD
Fluoxetine—Chills—Epirubicin—uterine cancer	7.22e-05	0.000231	CcSEcCtD
Fluoxetine—Pruritus—Etoposide—uterine cancer	7.21e-05	0.000231	CcSEcCtD
Fluoxetine—Arrhythmia—Epirubicin—uterine cancer	7.19e-05	0.00023	CcSEcCtD
Fluoxetine—Visual impairment—Doxorubicin—uterine cancer	7.17e-05	0.000229	CcSEcCtD
Fluoxetine—Alopecia—Epirubicin—uterine cancer	7.11e-05	0.000227	CcSEcCtD
Fluoxetine—Mental disorder—Epirubicin—uterine cancer	7.05e-05	0.000225	CcSEcCtD
Fluoxetine—Erythema multiforme—Doxorubicin—uterine cancer	7.04e-05	0.000225	CcSEcCtD
Fluoxetine—Malnutrition—Epirubicin—uterine cancer	7e-05	0.000224	CcSEcCtD
Fluoxetine—Diarrhoea—Etoposide—uterine cancer	6.97e-05	0.000223	CcSEcCtD
Fluoxetine—Tinnitus—Doxorubicin—uterine cancer	6.94e-05	0.000222	CcSEcCtD
Fluoxetine—Flatulence—Epirubicin—uterine cancer	6.9e-05	0.000221	CcSEcCtD
Fluoxetine—Tension—Epirubicin—uterine cancer	6.87e-05	0.00022	CcSEcCtD
Fluoxetine—Dysgeusia—Epirubicin—uterine cancer	6.86e-05	0.000219	CcSEcCtD
Fluoxetine—Nervousness—Epirubicin—uterine cancer	6.8e-05	0.000217	CcSEcCtD
Fluoxetine—Back pain—Epirubicin—uterine cancer	6.77e-05	0.000217	CcSEcCtD
Fluoxetine—Dizziness—Etoposide—uterine cancer	6.74e-05	0.000216	CcSEcCtD
Fluoxetine—Muscle spasms—Epirubicin—uterine cancer	6.73e-05	0.000215	CcSEcCtD
Fluoxetine—Chills—Doxorubicin—uterine cancer	6.68e-05	0.000213	CcSEcCtD
Fluoxetine—Arrhythmia—Doxorubicin—uterine cancer	6.65e-05	0.000213	CcSEcCtD
Fluoxetine—Alopecia—Doxorubicin—uterine cancer	6.58e-05	0.00021	CcSEcCtD
Fluoxetine—Mental disorder—Doxorubicin—uterine cancer	6.52e-05	0.000208	CcSEcCtD
Fluoxetine—Ill-defined disorder—Epirubicin—uterine cancer	6.5e-05	0.000208	CcSEcCtD
Fluoxetine—Vomiting—Etoposide—uterine cancer	6.48e-05	0.000207	CcSEcCtD
Fluoxetine—Malnutrition—Doxorubicin—uterine cancer	6.48e-05	0.000207	CcSEcCtD
Fluoxetine—Anaemia—Epirubicin—uterine cancer	6.47e-05	0.000207	CcSEcCtD
Fluoxetine—Agitation—Epirubicin—uterine cancer	6.43e-05	0.000206	CcSEcCtD
Fluoxetine—Rash—Etoposide—uterine cancer	6.43e-05	0.000205	CcSEcCtD
Fluoxetine—Dermatitis—Etoposide—uterine cancer	6.42e-05	0.000205	CcSEcCtD
Fluoxetine—Headache—Etoposide—uterine cancer	6.39e-05	0.000204	CcSEcCtD
Fluoxetine—Flatulence—Doxorubicin—uterine cancer	6.38e-05	0.000204	CcSEcCtD
Fluoxetine—Tension—Doxorubicin—uterine cancer	6.36e-05	0.000203	CcSEcCtD
Fluoxetine—Dysgeusia—Doxorubicin—uterine cancer	6.34e-05	0.000203	CcSEcCtD
Fluoxetine—Malaise—Epirubicin—uterine cancer	6.31e-05	0.000202	CcSEcCtD
Fluoxetine—Nervousness—Doxorubicin—uterine cancer	6.29e-05	0.000201	CcSEcCtD
Fluoxetine—Vertigo—Epirubicin—uterine cancer	6.29e-05	0.000201	CcSEcCtD
Fluoxetine—Syncope—Epirubicin—uterine cancer	6.28e-05	0.000201	CcSEcCtD
Fluoxetine—Leukopenia—Epirubicin—uterine cancer	6.27e-05	0.0002	CcSEcCtD
Fluoxetine—Back pain—Doxorubicin—uterine cancer	6.27e-05	0.0002	CcSEcCtD
Fluoxetine—Muscle spasms—Doxorubicin—uterine cancer	6.23e-05	0.000199	CcSEcCtD
Fluoxetine—Palpitations—Epirubicin—uterine cancer	6.19e-05	0.000198	CcSEcCtD
Fluoxetine—Loss of consciousness—Epirubicin—uterine cancer	6.15e-05	0.000197	CcSEcCtD
Fluoxetine—Cough—Epirubicin—uterine cancer	6.11e-05	0.000195	CcSEcCtD
Fluoxetine—Convulsion—Epirubicin—uterine cancer	6.07e-05	0.000194	CcSEcCtD
Fluoxetine—Nausea—Etoposide—uterine cancer	6.06e-05	0.000194	CcSEcCtD
Fluoxetine—Hypertension—Epirubicin—uterine cancer	6.05e-05	0.000193	CcSEcCtD
Fluoxetine—Ill-defined disorder—Doxorubicin—uterine cancer	6.01e-05	0.000192	CcSEcCtD
Fluoxetine—Anaemia—Doxorubicin—uterine cancer	5.99e-05	0.000191	CcSEcCtD
Fluoxetine—Arthralgia—Epirubicin—uterine cancer	5.96e-05	0.000191	CcSEcCtD
Fluoxetine—Chest pain—Epirubicin—uterine cancer	5.96e-05	0.000191	CcSEcCtD
Fluoxetine—Myalgia—Epirubicin—uterine cancer	5.96e-05	0.000191	CcSEcCtD
Fluoxetine—Agitation—Doxorubicin—uterine cancer	5.95e-05	0.00019	CcSEcCtD
Fluoxetine—Anxiety—Epirubicin—uterine cancer	5.94e-05	0.00019	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.92e-05	0.000189	CcSEcCtD
Fluoxetine—Discomfort—Epirubicin—uterine cancer	5.89e-05	0.000188	CcSEcCtD
Fluoxetine—Malaise—Doxorubicin—uterine cancer	5.84e-05	0.000187	CcSEcCtD
Fluoxetine—Dry mouth—Epirubicin—uterine cancer	5.83e-05	0.000186	CcSEcCtD
Fluoxetine—Vertigo—Doxorubicin—uterine cancer	5.82e-05	0.000186	CcSEcCtD
Fluoxetine—Syncope—Doxorubicin—uterine cancer	5.81e-05	0.000186	CcSEcCtD
Fluoxetine—Leukopenia—Doxorubicin—uterine cancer	5.8e-05	0.000185	CcSEcCtD
Fluoxetine—Confusional state—Epirubicin—uterine cancer	5.76e-05	0.000184	CcSEcCtD
Fluoxetine—Palpitations—Doxorubicin—uterine cancer	5.73e-05	0.000183	CcSEcCtD
Fluoxetine—Anaphylactic shock—Epirubicin—uterine cancer	5.71e-05	0.000183	CcSEcCtD
Fluoxetine—Loss of consciousness—Doxorubicin—uterine cancer	5.69e-05	0.000182	CcSEcCtD
Fluoxetine—Infection—Epirubicin—uterine cancer	5.68e-05	0.000181	CcSEcCtD
Fluoxetine—Cough—Doxorubicin—uterine cancer	5.65e-05	0.000181	CcSEcCtD
Fluoxetine—Shock—Epirubicin—uterine cancer	5.62e-05	0.00018	CcSEcCtD
Fluoxetine—Convulsion—Doxorubicin—uterine cancer	5.61e-05	0.000179	CcSEcCtD
Fluoxetine—Thrombocytopenia—Epirubicin—uterine cancer	5.59e-05	0.000179	CcSEcCtD
Fluoxetine—Hypertension—Doxorubicin—uterine cancer	5.59e-05	0.000179	CcSEcCtD
Fluoxetine—Tachycardia—Epirubicin—uterine cancer	5.58e-05	0.000178	CcSEcCtD
Fluoxetine—Skin disorder—Epirubicin—uterine cancer	5.55e-05	0.000177	CcSEcCtD
Fluoxetine—Hyperhidrosis—Epirubicin—uterine cancer	5.52e-05	0.000177	CcSEcCtD
Fluoxetine—Myalgia—Doxorubicin—uterine cancer	5.52e-05	0.000176	CcSEcCtD
Fluoxetine—Arthralgia—Doxorubicin—uterine cancer	5.52e-05	0.000176	CcSEcCtD
Fluoxetine—Chest pain—Doxorubicin—uterine cancer	5.52e-05	0.000176	CcSEcCtD
Fluoxetine—Anxiety—Doxorubicin—uterine cancer	5.5e-05	0.000176	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.48e-05	0.000175	CcSEcCtD
Fluoxetine—Discomfort—Doxorubicin—uterine cancer	5.45e-05	0.000174	CcSEcCtD
Fluoxetine—Anorexia—Epirubicin—uterine cancer	5.45e-05	0.000174	CcSEcCtD
Fluoxetine—Dry mouth—Doxorubicin—uterine cancer	5.39e-05	0.000172	CcSEcCtD
Fluoxetine—Hypotension—Epirubicin—uterine cancer	5.34e-05	0.000171	CcSEcCtD
Fluoxetine—Confusional state—Doxorubicin—uterine cancer	5.33e-05	0.00017	CcSEcCtD
Fluoxetine—Anaphylactic shock—Doxorubicin—uterine cancer	5.29e-05	0.000169	CcSEcCtD
Fluoxetine—Infection—Doxorubicin—uterine cancer	5.25e-05	0.000168	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.21e-05	0.000166	CcSEcCtD
Fluoxetine—Shock—Doxorubicin—uterine cancer	5.2e-05	0.000166	CcSEcCtD
Fluoxetine—Thrombocytopenia—Doxorubicin—uterine cancer	5.18e-05	0.000165	CcSEcCtD
Fluoxetine—Insomnia—Epirubicin—uterine cancer	5.17e-05	0.000165	CcSEcCtD
Fluoxetine—Tachycardia—Doxorubicin—uterine cancer	5.16e-05	0.000165	CcSEcCtD
Fluoxetine—Skin disorder—Doxorubicin—uterine cancer	5.14e-05	0.000164	CcSEcCtD
Fluoxetine—Paraesthesia—Epirubicin—uterine cancer	5.13e-05	0.000164	CcSEcCtD
Fluoxetine—Hyperhidrosis—Doxorubicin—uterine cancer	5.11e-05	0.000163	CcSEcCtD
Fluoxetine—Dyspnoea—Epirubicin—uterine cancer	5.09e-05	0.000163	CcSEcCtD
Fluoxetine—Somnolence—Epirubicin—uterine cancer	5.08e-05	0.000162	CcSEcCtD
Fluoxetine—Anorexia—Doxorubicin—uterine cancer	5.04e-05	0.000161	CcSEcCtD
Fluoxetine—Dyspepsia—Epirubicin—uterine cancer	5.03e-05	0.000161	CcSEcCtD
Fluoxetine—Decreased appetite—Epirubicin—uterine cancer	4.97e-05	0.000159	CcSEcCtD
Fluoxetine—Hypotension—Doxorubicin—uterine cancer	4.94e-05	0.000158	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Epirubicin—uterine cancer	4.93e-05	0.000158	CcSEcCtD
Fluoxetine—Fatigue—Epirubicin—uterine cancer	4.93e-05	0.000157	CcSEcCtD
Fluoxetine—Pain—Epirubicin—uterine cancer	4.89e-05	0.000156	CcSEcCtD
Fluoxetine—Constipation—Epirubicin—uterine cancer	4.89e-05	0.000156	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.82e-05	0.000154	CcSEcCtD
Fluoxetine—Insomnia—Doxorubicin—uterine cancer	4.78e-05	0.000153	CcSEcCtD
Fluoxetine—Paraesthesia—Doxorubicin—uterine cancer	4.75e-05	0.000152	CcSEcCtD
Fluoxetine—Dyspnoea—Doxorubicin—uterine cancer	4.71e-05	0.000151	CcSEcCtD
Fluoxetine—Feeling abnormal—Epirubicin—uterine cancer	4.71e-05	0.000151	CcSEcCtD
Fluoxetine—Somnolence—Doxorubicin—uterine cancer	4.7e-05	0.00015	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Epirubicin—uterine cancer	4.67e-05	0.000149	CcSEcCtD
Fluoxetine—Dyspepsia—Doxorubicin—uterine cancer	4.65e-05	0.000149	CcSEcCtD
Fluoxetine—Decreased appetite—Doxorubicin—uterine cancer	4.6e-05	0.000147	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.56e-05	0.000146	CcSEcCtD
Fluoxetine—Fatigue—Doxorubicin—uterine cancer	4.56e-05	0.000146	CcSEcCtD
Fluoxetine—Urticaria—Epirubicin—uterine cancer	4.54e-05	0.000145	CcSEcCtD
Fluoxetine—Constipation—Doxorubicin—uterine cancer	4.52e-05	0.000145	CcSEcCtD
Fluoxetine—Pain—Doxorubicin—uterine cancer	4.52e-05	0.000145	CcSEcCtD
Fluoxetine—Abdominal pain—Epirubicin—uterine cancer	4.52e-05	0.000144	CcSEcCtD
Fluoxetine—Body temperature increased—Epirubicin—uterine cancer	4.52e-05	0.000144	CcSEcCtD
Fluoxetine—Feeling abnormal—Doxorubicin—uterine cancer	4.36e-05	0.000139	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Doxorubicin—uterine cancer	4.32e-05	0.000138	CcSEcCtD
Fluoxetine—Hypersensitivity—Epirubicin—uterine cancer	4.21e-05	0.000135	CcSEcCtD
Fluoxetine—Urticaria—Doxorubicin—uterine cancer	4.2e-05	0.000134	CcSEcCtD
Fluoxetine—Abdominal pain—Doxorubicin—uterine cancer	4.18e-05	0.000134	CcSEcCtD
Fluoxetine—Body temperature increased—Doxorubicin—uterine cancer	4.18e-05	0.000134	CcSEcCtD
Fluoxetine—Asthenia—Epirubicin—uterine cancer	4.1e-05	0.000131	CcSEcCtD
Fluoxetine—Pruritus—Epirubicin—uterine cancer	4.04e-05	0.000129	CcSEcCtD
Fluoxetine—Diarrhoea—Epirubicin—uterine cancer	3.91e-05	0.000125	CcSEcCtD
Fluoxetine—Hypersensitivity—Doxorubicin—uterine cancer	3.9e-05	0.000125	CcSEcCtD
Fluoxetine—Asthenia—Doxorubicin—uterine cancer	3.79e-05	0.000121	CcSEcCtD
Fluoxetine—Dizziness—Epirubicin—uterine cancer	3.78e-05	0.000121	CcSEcCtD
Fluoxetine—Pruritus—Doxorubicin—uterine cancer	3.74e-05	0.00012	CcSEcCtD
Fluoxetine—Vomiting—Epirubicin—uterine cancer	3.63e-05	0.000116	CcSEcCtD
Fluoxetine—Diarrhoea—Doxorubicin—uterine cancer	3.62e-05	0.000116	CcSEcCtD
Fluoxetine—Rash—Epirubicin—uterine cancer	3.6e-05	0.000115	CcSEcCtD
Fluoxetine—Dermatitis—Epirubicin—uterine cancer	3.6e-05	0.000115	CcSEcCtD
Fluoxetine—Headache—Epirubicin—uterine cancer	3.58e-05	0.000114	CcSEcCtD
Fluoxetine—Dizziness—Doxorubicin—uterine cancer	3.5e-05	0.000112	CcSEcCtD
Fluoxetine—Nausea—Epirubicin—uterine cancer	3.39e-05	0.000109	CcSEcCtD
Fluoxetine—Vomiting—Doxorubicin—uterine cancer	3.36e-05	0.000107	CcSEcCtD
Fluoxetine—Rash—Doxorubicin—uterine cancer	3.33e-05	0.000107	CcSEcCtD
Fluoxetine—Dermatitis—Doxorubicin—uterine cancer	3.33e-05	0.000106	CcSEcCtD
Fluoxetine—Headache—Doxorubicin—uterine cancer	3.31e-05	0.000106	CcSEcCtD
Fluoxetine—Nausea—Doxorubicin—uterine cancer	3.14e-05	0.0001	CcSEcCtD
